208 related articles for article (PubMed ID: 38235169)
1. Biliary disease progression in childhood onset autoimmune liver disease: A 30-year follow-up into adulthood.
Warner S; Rajanayagam J; Russell E; Lloyd C; Ferguson J; Kelly DA; Hirschfield GM
JHEP Rep; 2024 Feb; 6(2):100901. PubMed ID: 38235169
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of Autoimmune Liver Disease and Real-World Treatment Experience from a Tertiary Care Hospital.
Taneja S; Mehtani R; De A; Mitra S; Rathi S; Verma N; Premkumar M; Minz R; Duseja A; Das A; Singh V; Dhiman RK; Chawla YK
J Clin Exp Hepatol; 2023; 13(2):241-251. PubMed ID: 36950480
[TBL] [Abstract][Full Text] [Related]
3. Biliary features in liver histology of children with autoimmune liver disease.
Di Giorgio A; D'Adda A; Marseglia A; Sonzogni A; Licini L; Nicastro E; D'Antiga L
Hepatol Int; 2019 Jul; 13(4):510-518. PubMed ID: 31069759
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
Maggiore G; Riva S; Sciveres M
Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease.
Vesterhus M; Nielsen MJ; Hov JR; Saffioti F; Manon-Jensen T; Leeming DJ; Moum B; Boberg KM; Pinzani M; Karlsen TH; Karsdal MA; Thorburn D
JHEP Rep; 2021 Feb; 3(1):100178. PubMed ID: 33225252
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of autoimmune liver disease natural history in patients referred to Middle East Liver Diseases (MELD) center.
Nejad SEM; Heiat M; Javanbakht M; Alavian SM; Haris MAA
BMC Gastroenterol; 2024 Jan; 24(1):17. PubMed ID: 38178070
[TBL] [Abstract][Full Text] [Related]
7. Clinical course and prognosis of pediatric-onset primary sclerosing cholangitis.
Tenca A; Färkkilä M; Arola J; Jaakkola T; Penagini R; Kolho KL
United European Gastroenterol J; 2016 Aug; 4(4):562-9. PubMed ID: 27536366
[TBL] [Abstract][Full Text] [Related]
8. Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases.
Rocha HC; Vilela EG
Gastroenterol Hepatol; 2022 Feb; 45(2):83-90. PubMed ID: 34023469
[TBL] [Abstract][Full Text] [Related]
9. Evolving Practice and Changing Phenotype in Pediatric Autoimmune Liver Disease: Outcomes From an Australian Center.
Singh H; Balouch F; Noble C; Lewindon P
J Pediatr Gastroenterol Nutr; 2018 Jul; 67(1):80-85. PubMed ID: 29470284
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study.
Gregorio GV; Portmann B; Karani J; Harrison P; Donaldson PT; Vergani D; Mieli-Vergani G
Hepatology; 2001 Mar; 33(3):544-53. PubMed ID: 11230733
[TBL] [Abstract][Full Text] [Related]
11. Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease.
Saich R; Chapman R
World J Gastroenterol; 2008 Jan; 14(3):331-7. PubMed ID: 18200656
[TBL] [Abstract][Full Text] [Related]
12. Ulcerative colitis complicated by primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome: a case report and literature review.
Zhang X; Lin X; Li X; Guan L; Li Y; Wang N
Front Immunol; 2023; 14():1132072. PubMed ID: 37228618
[TBL] [Abstract][Full Text] [Related]
13. [Autoimmune liver diseases and their overlap syndromes].
Strassburg CP
Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
[TBL] [Abstract][Full Text] [Related]
14. Primary sclerosing cholangitis and overlap features of autoimmune hepatitis: A coming of age or an age-ist problem?
Ricciuto A; Kamath BM; Hirschfield GM; Trivedi PJ
J Hepatol; 2023 Aug; 79(2):567-575. PubMed ID: 36870613
[TBL] [Abstract][Full Text] [Related]
15. The Epidemiology of UK Autoimmune Liver Disease Varies With Geographic Latitude.
Webb GJ; Ryan RP; Marshall TP; Hirschfield GM
Clin Gastroenterol Hepatol; 2021 Dec; 19(12):2587-2596. PubMed ID: 33493696
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of controlled attenuation parameter measurement for the detection of steatosis in autoimmune liver diseases.
Steinmann S; Hartl J; Weidemann S; Füssel K; Kroll C; Sebode M; Lohse AW; Schramm C
JHEP Rep; 2023 Dec; 5(12):100898. PubMed ID: 37954487
[TBL] [Abstract][Full Text] [Related]
17. [Autoimmune hepatitis and overlap syndrome: diagnosis].
Berg PA; Klein R
Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
[TBL] [Abstract][Full Text] [Related]
18. Ulcerative colitis complicated by autoimmune hepatitis-primary biliary cholangitis-primary sclerosing cholangitis overlap syndrome.
Jing M; Zhang W; Xia M
Rev Esp Enferm Dig; 2022 Dec; 114(12):765-766. PubMed ID: 36205327
[TBL] [Abstract][Full Text] [Related]
19. Rapid progression of autoimmune hepatitis in the background of primary sclerosing cholangitis.
Hong-Curtis J; Yeh MM; Jain D; Lee JH
J Clin Gastroenterol; 2004; 38(10):906-9. PubMed ID: 15492611
[TBL] [Abstract][Full Text] [Related]
20. Twenty-Year Comparative Analysis of Patients With Autoimmune Liver Diseases on Transplant Waitlists.
Webb GJ; Rana A; Hodson J; Akhtar MZ; Ferguson JW; Neuberger JM; Vierling JM; Hirschfield GM
Clin Gastroenterol Hepatol; 2018 Feb; 16(2):278-287.e7. PubMed ID: 28993258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
